CPT 86789 West Nile Non-IgM Immunoassay Reimbursement

CPT code 86789 represents an immunoassay performed on serum or cerebrospinal fluid to detect antibodies other than IgM to West Nile virus (WNV). This serologic test supports diagnosis of prior or ongoing WNV infection, including neuroinvasive presentations such as meningoencephalitis, and informs clinical management and public health surveillance. Nationally, WNV testing is an element of arboviral disease workups and laboratory public-health coordination, making this code relevant for hospitals, reference laboratories, and outpatient testing centers.

Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. The publication outlines expected use cases for the assay, typical sites of service, and how this code fits into laboratory service lines. Readers will find benchmarks for utilization and reimbursement (where available), summary clinical context for when non-IgM antibody testing is used versus other WNV assays, and notes on payer coverage patterns and billing considerations. Data not available in the input is noted where applicable. The content is intended for billing professionals, laboratory managers, and policy analysts seeking a concise reference to CPT code 86789 and its clinical and billing context.

Billing Code Overview

CPT code 86789 describes an immunoassay for detection of antibodies (other than IgM) to West Nile virus (WNV) in a patient's serum or cerebrospinal fluid. The test evaluates the presence of non-IgM antibodies to WNV, a flavivirus that can cause meningoencephalitis and other neuroinvasive disease.

Service Type: Laboratory / Infectious Disease Serology

Typical Site of Service: Clinical laboratory or hospital laboratory; specimen collection commonly occurs in outpatient clinics, emergency departments, or inpatient settings depending on clinical presentation.

Clinical Context

A typical patient is an adult or pediatric patient presenting to an emergency department, inpatient unit, or outpatient infectious disease/neurology clinic with acute febrile illness and neurologic symptoms such as headache, confusion, photophobia, neck stiffness, focal neurologic deficits, or altered mental status. The clinician suspects arboviral infection, particularly West Nile virus (WNV), and orders serologic testing for WNV antibodies. The laboratory performs an immunoassay to detect WNV-specific IgG or non-IgM antibody classes in serum or cerebrospinal fluid (CSF) to support a diagnosis of prior or recent infection, to complement IgM testing, or to help interpret serologic results in convalescent samples.

Specimen collection follows standard phlebotomy for serum or lumbar puncture for CSF. Results are interpreted in the context of timing of symptom onset, prior vaccination or travel history, and other laboratory findings (e.g., WNV IgM, PCR when available). Typical ordering providers include emergency physicians, internists, neurologists, infectious disease specialists, and pediatricians. The test is performed in a clinical laboratory with appropriate immunoassay platforms, and results are reported with reference ranges, assay type, and any limitations (cross-reactivity with other flaviviruses).

Coding Specifications

Modifier	Description	When to Use
`26`	Professional component	Use when billing only the professional interpretation component if split billing applies.

Taxonomy Code	Specialty	Notes
207Q00000X	Infectious Disease	Physicians who order and interpret serologic testing for WNV.
2084P0800X	Neurology	Neurologists evaluating meningoencephalitis who order CSF and serologic testing.
207L00000X	Emergency Medicine	Emergency physicians who evaluate acute febrile neurologic presentations and order initial testing.
208000000X	Pediatrics	Pediatricians evaluating suspected WNV in children or infants.
354W00000X	Clinical Laboratory	Laboratory directors and pathologists overseeing immunoassay testing and reporting.

Related Diagnoses

ICD-10 Code	Description	Clinical Relevance
`A92.29`	Other mosquito-borne viral fevers	Used for confirmed or suspected arboviral infections including West Nile when specific code for WNV is not used.
`A92.89`	Other specified arthropod-borne viral fevers	Used for documented WNV infection when coding requires an other specified arboviral fever.
`A83.9`	Viral meningitis, unspecified	Applied when a patient presents with meningitis and WNV testing is performed as part of workup.
`G04.90`	Encephalitis, unspecified, without status epilepticus	Used when encephalitis is suspected and WNV is among differential etiologies prompting antibody testing.
`R50.9`	Fever, unspecified	Common presenting symptom prompting evaluation for infectious causes including WNV.
`G04.81`	Encephalitis and encephalomyelitis in diseases classified elsewhere	Used when neurologic inflammation is linked to an identified infectious agent such as WNV.
`A92.89`	Other mosquito-borne viral fevers	Included for relevance to arboviral serologic testing in differential diagnosis.

Related CPT Codes

CPT Code	Description	Relationship to This Procedure
`86785`	Antibody; West Nile virus, IgM (immunoassay)	Often ordered concurrently to detect acute/recent infection; `86789` assesses non-IgM antibodies (e.g., IgG) for prior or later-stage infection.
`86312`	Antibody; multiple types, qualitative or semiquantitative, each antigen (e.g., arbovirus panels)	May be used when a panel or multiple antibody types are tested alongside WNV-specific assays.
`36415`	Collection of venous blood by venipuncture	Performed prior to serum immunoassay; typically billed by the facility or phlebotomy service.
`62270`	Spinal puncture, diagnostic (lumbar puncture)	Performed when CSF is collected for WNV testing in suspected meningitis/encephalitis.
`87449`	Infectious agent detection by nucleic acid (e.g., West Nile virus), amplified probe technique	Molecular testing that may be performed in parallel for early infection when PCR is indicated.

OpenPayer

Summary & Overview

CPT 86789: West Nile Virus Non-IgM Antibody Immunoassay